| Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement, Clinical Trial Optional)- PA-18-935 |
Supp
|
October 03, 2018 |
January 25, 2022 |
| Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)- PA-19-020 |
R21
|
October 05, 2018 |
January 08, 2022 |
| Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)- PA-19-066 |
R21
|
November 13, 2018 |
January 08, 2022 |
| Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)- PA-19-067 |
R01
|
November 13, 2018 |
January 08, 2022 |
| Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-19-078 |
R01
|
November 26, 2018 |
January 08, 2022 |
| Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-079 |
R21
|
November 26, 2018 |
January 08, 2022 |
| Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)- PA-19-077 |
R01
|
November 26, 2018 |
January 08, 2022 |
| Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)- PA-19-080 |
R01
|
November 26, 2018 |
January 08, 2022 |
| Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)- PA-19-081 |
R21
|
November 26, 2018 |
January 08, 2022 |
| Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)- PA-19-082 |
R01
|
November 26, 2018 |
January 08, 2022 |
| Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)- PA-19-083 |
R21
|
November 26, 2018 |
January 08, 2022 |
| Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)- PA-19-096 |
R01
|
November 29, 2018 |
January 08, 2022 |
| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)- PAR-19-134 |
R15
|
December 21, 2018 |
January 08, 2022 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)- PAR-19-158 |
R01
|
January 08, 2019 |
January 08, 2022 |
| Notice of Special Interest (NOSI)—Research on the Health of Sexual and Gender Minority (SGM) Populations- NOT-MD-19-001 |
Multiple |
March 13, 2019 |
|
| Novel RNAs in Virology (including HIV) and Immune Regulation—Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)- PA-19-237 |
R21
|
April 03, 2019 |
May 08, 2022 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-19-274 |
R01
|
May 08, 2019 |
May 08, 2022 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-19-275 |
R21
|
May 08, 2019 |
May 08, 2022 |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)- PAR-19-364 |
R21
|
September 03, 2019 |
January 11, 2022 |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)- PAR-19-357 |
R01
|
September 03, 2019 |
January 11, 2022 |
| Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)- RFA-HL-20-006 |
K38
|
September 09, 2019 |
January 15, 2022 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)- PAR-19-371 |
K22
|
September 09, 2019 |
January 08, 2022 |
| The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)- RFA-OD-19-029 |
R01
|
September 27, 2019 |
November 27, 2021 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)- PAR-20-029 |
R01
|
October 10, 2019 |
January 08, 2022 |
| Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 |
R01
|
October 24, 2019 |
September 08, 2022 |
